In vitro and in vivo Activity of Combinations of Polymyxin B with Other Antimicrobials Against Carbapenem-Resistant Acinetobacter baumannii [Corrigendum]

This article refers to:

In vitro and in vivo Activity of Combinations of Polymyxin B with Other Antimicrobials Against Carbapenem-Resistant Acinetobacter baumannii

Zhang H, Zhu Y, Yang N, et al. Infect Drug Resist. 2021;14:4657–4666.

Page 4660, Table 1, Notes: section, the text “RIF, susceptible ≤2, resistant ≥4 (according to Working Party Report of BSAC);” should read “RIF, susceptible ≤2, resistant ≥4 (breakpoints based on Tan et al³⁷ and Bai et al³⁸);”.

The authors also wish to add the following two references to the end of the reference section on page 4666.

37. Tan TY, Ng LS, Poh K. Susceptibility testing of unconventional antibiotics against multiresistant Acinetobacter spp. by agar dilution and Vitek 2. Diagn Microbiol Infect Dis. 2007;58(3):357-361. doi:10.1016/j.diagmicrobio.2007.02.008

38. Bai Y, Liu B, Wang T, et al. In Vitro activities of combinations of rifampin with other antimicrobials against multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2015;59(3):1466-1471. doi:10.1128/AAC.04089-14

The authors apologize for this error.